selected publications
- Natural history of lower urinary tract symptoms among men undergoing stereotactic body radiation therapy for prostate cancer with and without a Rectal Hydrogel Spacer. World journal of urology. 2022 Academic Article GET IT
- Quantifying the impact of SpaceOAR hydrogel on inter-fractional rectal and bladder dose during 0.35 T MR-guided prostate adaptive radiotherapy. Journal of applied clinical medical physics. 2021 Academic Article GET IT
-
Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States.
JAMA network open.
2020
Academic Article
GET IT
Times cited: 19 -
Combining Immunotherapy with Radiotherapy for the Treatment of Genitourinary Malignancies.
European urology oncology.
2018
Review
GET IT
Times cited: 14 -
PD-L1 blockade for urothelial carcinoma.
Oncoimmunology.
2017
Editorial Article
GET IT
Times cited: 5 - Radiation Oncology Physician Practice in the Modern Era: A Statewide Analysis of Medicare Reimbursement. Cureus. 2017 Academic Article GET IT
- Reply to Serin et al. Journal of pain and symptom management. 2017 Article GET IT
-
Impact of Radiation Therapy on Aggressive Care and Quality of Life Near Death.
Journal of pain and symptom management.
2016
Academic Article
GET IT
Times cited: 11 -
Current clinical trials testing the combination of immunotherapy with radiotherapy.
Journal for immunotherapy of cancer.
2016
Academic Article
GET IT
Times cited: 306 -
Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of Failure.
Frontiers in oncology.
2016
Academic Article
GET IT
Times cited: 48 -
Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer.
Cancer.
2016
Academic Article
GET IT
Times cited: 66 -
Minimally invasive local therapies for liver cancer.
Cancer biology & medicine.
2014
Review
GET IT
Times cited: 61 -
Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study.
Frontiers in oncology.
2014
Academic Article
GET IT
Times cited: 95 -
Stereotactic body radiotherapy as treatment for organ confined low- and intermediate-risk prostate carcinoma, a 7-year study.
Frontiers in oncology.
2014
Academic Article
GET IT
Times cited: 77 -
Locally ablative therapies for primary and metastatic liver cancer.
Expert review of anticancer therapy.
2014
Review
GET IT
Times cited: 29 -
Association between urinary cadmium and all cause, all cancer and prostate cancer specific mortalities for men: an analysis of national health and nutrition examination survey (NHANES III) data.
Asian Pacific journal of cancer prevention : APJCP.
2014
Academic Article
GET IT
Times cited: 16 -
Socio-economic factors affect the outcome of soft tissue sarcoma: an analysis of SEER data.
Asian Pacific journal of cancer prevention : APJCP.
2014
Academic Article
GET IT
Times cited: 5 -
Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year study.
Radiation oncology (London, England).
2014
Academic Article
GET IT
Times cited: 33 -
The use of radiation therapy in the management of selected patients with atypical lipomas.
Sarcoma.
2013
Academic Article
GET IT
Times cited: 6 -
Re: A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy.
Journal of the National Cancer Institute.
2012
Letter
GET IT
Times cited: 1 -
A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy.
Journal of the National Cancer Institute.
2012
Academic Article
GET IT
Times cited: 138 -
Type of diabetes mellitus and the odds of Gleason score 8 to 10 prostate cancer.
International journal of radiation oncology, biology, physics.
2011
Academic Article
GET IT
Times cited: 24 -
Outcomes after combined modality therapy for EGFR-mutant and wild-type locally advanced NSCLC.
The oncologist.
2011
Academic Article
GET IT
Times cited: 54 -
Repair and antirepair DNA helicases in Helicobacter pylori.
Journal of bacteriology.
2008
Academic Article
GET IT
Times cited: 19 -
Plastic cells and populations: DNA substrate characteristics in Helicobacter pylori transformation define a flexible but conservative system for genomic variation.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
2007
Academic Article
GET IT
Times cited: 44 -
A paradigm for direct stress-induced mutation in prokaryotes.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
2006
Academic Article
GET IT
Times cited: 24 -
Bacterial populations as perfect gases: genomic integrity and diversification tensions in Helicobacter pylori.
Nature reviews. Microbiology.
2006
Review
GET IT
Times cited: 84 -
Antimutator role of the DNA glycosylase mutY gene in Helicobacter pylori.
Journal of bacteriology.
2006
Academic Article
GET IT
Times cited: 34 -
UvrD helicase suppresses recombination and DNA damage-induced deletions.
Journal of bacteriology.
2006
Academic Article
GET IT
Times cited: 32 -
Structural and functional divergence of MutS2 from bacterial MutS1 and eukaryotic MSH4-MSH5 homologs.
Journal of bacteriology.
2005
Academic Article
GET IT
Times cited: 51 -
Effect of host species on recG phenotypes in Helicobacter pylori and Escherichia coli.
Journal of bacteriology.
2004
Academic Article
GET IT
Times cited: 26 -
Extensive repetitive DNA facilitates prokaryotic genome plasticity.
Proceedings of the National Academy of Sciences of the United States of America.
2003
Academic Article
GET IT
Times cited: 109